Transchem Limited.

Rs 38.00

Closing Price Date 28-Jun-2024

BSE 500422

Category Healthcare

SC NAME:

TRANSCHEM

Market Cap:

46.5

High / Low:

50.7 / 20.5

Stock P/E:

11.1

Book Value:

61.8

Dividend Yield:

0.00

ROCE:

7.99

ROE:

5.94

Face Value:

10.0

PEG Ratio:

0.15

EVEBITDA:

8.16

Debt:

0.00

CMP / FCF:

-8.60

Debt to equity:

0.00

NP Ann:

4.20

High price all time:

50.7

Piotroski score:

5.00

Graham Number:

69.1

No. Eq. Shares:

1.22

Net CF:

-34.2

Net profit:

4.20

Price to book value:

0.61

Interest Coverage:

Low price all time:

5.01

Reserves:

63.4

Industry PE:

34.1

Free Cash Flow:

-39.3

Short Description

Transchem Limited. specializes in Pharmaceuticals within the Healthcare sector.

Long Description

Transchem Limited., with Security Code 500422, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	4.10	12.54	25.73	1.02	-	21.63	-0.02	17.08
2023-10-01	2023-12-31	-	11.36	20.20	0.93	-	20.20	-0.02	15.21
2023-07-01	2023-09-30	-	9.67	16.87	0.79	-	16.87	-0.02	12.96
2023-04-01	2023-06-30	-	8.47	15.28	0.69	-	15.28	-0.02	11.28
2023-01-01	2023-03-31	-	4.08	10.32	0.33	-	10.32	-0.02	5.44
2022-10-01	2022-12-31	-	-1.49	10.46	-0.12	-	10.46	-0.02	6.36
2022-07-01	2022-09-30	-	4.17	10.40	0.34	-	10.40	-0.02	5.61
2022-04-01	2022-06-30	-	5.62	11.27	0.46	-	11.27	-0.02	7.62
2022-01-01	2022-03-31	-	5.71	23.95	0.47	-	23.95	-0.02	8.28
2021-10-01	2021-12-31	-	7.89	14.30	0.64	-	14.30	-0.02	10.58
2021-07-01	2021-09-30	-	6.68	13.93	0.55	-	13.93	-0.02	8.98
2021-04-01	2021-06-30	-	8.40	14.42	0.69	-	14.42	-0.02	11.24
2021-01-01	2021-03-31	-	5.80	12.82	0.47	-	12.82	-0.02	7.82
2020-10-01	2020-12-31	-	7.23	12.65	0.59	-	12.65	-0.02	9.08
2020-07-01	2020-09-30	-	3.11	11.22	0.26	-	11.22	-0.02	4.10
2020-04-01	2020-06-30	-	225.36	231.63	18.41	-	231.63	-1.19	226.69
2020-01-01	2020-03-31	-	-0.46	6.67	-0.04	-	6.67	-1.42	-0.08
2019-10-01	2019-12-31	-	1.11	6.90	0.09	-1.43	6.90	-1.42	2.31
2019-07-01	2019-09-30	-	1.90	7.48	0.16	-	7.48	-1.47	3.03
2019-04-01	2019-06-30	-	1.54	6.54	0.13	-	6.54	-1.42	2.66
2019-01-01	2019-03-31	-	-2.26	7.36	-0.18	-	7.36	-1.42	2.44
2018-10-01	2018-12-31	-	0.74	7.39	0.06	-	7.39	-1.76	0.74
2018-07-01	2018-09-30	-	1.56	7.39	-	-2.49	7.39	-2.40	1.56
2018-04-01	2018-06-30	-	3.01	7.13	-	-	7.13	-2.40	3.01
2018-01-01	2018-03-31	-	-5.33	6.77	-	-	6.77	-2.42	1.06
2017-10-01	2017-12-31	-	1.51	5.62	-	-	5.62	-2.42	1.51
2017-07-01	2017-09-30	-	-7.51	4.53	-	-2.03	4.53	-2.42	-7.51
2017-04-01	2017-06-30	-	-0.56	4.19	-	-	4.19	-2.42	-0.56
2017-01-01	2017-03-31	-	-2.82	4.11	-	-	4.11	-	-2.82
2016-10-01	2016-12-31	-	-2.18	-	-	-	4.24	-	-2.18
2016-07-01	2016-09-30	-	-0.02	-	-	-	4.61	-	-0.02
2016-04-01	2016-06-30	-	0.90	-	-	-	4.81	-	0.90
2016-01-01	2016-03-31	-	0.51	-	-	-	5.06	-	0.51
2015-10-01	2015-12-31	-	-0.71	-	-	-	4.57	-	-0.71
2015-07-01	2015-09-30	-	0.69	-	-	-	5.04	-	0.69
2015-04-01	2015-06-30	-	-0.02	-	-	-	4.99	-	-0.02
2015-01-01	2015-03-31	-	2.88	-	-	-	5.07	-	2.88
2014-10-01	2014-12-31	-	-0.60	-	-	-	5.05	-	-0.60
2014-07-01	2014-09-30	-	-1.40	-	-	-	4.99	-	-1.40
2014-04-01	2014-06-30	-	0.29	-	-	-	5.75	-	0.29
2014-01-01	2014-03-31	-	-0.75	-	-	-	4.70	-	-0.39
2013-10-01	2013-12-31	-	-0.11	-	-	-	6.02	-	-0.11
2013-07-01	2013-09-30	-	-4.54	-	-	-	1.73	-	-4.54
2013-04-01	2013-06-30	-	-2.65	-	-	-	5.96	-	-2.65
2013-01-01	2013-03-31	-	-7.08	-	-	-	4.53	-	-6.57

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	4.10	12.54	25.73	1.02	-	21.63	-0.02	17.08
2023-10-01	2023-12-31	-	11.36	20.20	0.93	-	20.20	-0.02	15.21
2023-07-01	2023-09-30	-	9.67	16.87	0.79	-	16.87	-0.02	12.96
2023-04-01	2023-06-30	-	8.47	15.28	0.69	-	15.28	-0.02	11.28

Compounded Data

Standalone

Consolidated

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	22%
5 Years:	76%
3 Years:	23%
TTM:	282%

Stock Price CAGR
10 Years:	3%
5 Years:	14%
3 Years:	9%
1 Year:	69%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	0%

Latest News

Transchem Limited Announces New Contract with Major Petrochemical Company
Transchem Limited, a leading provider of specialty chemicals and services to the petrochemical industry, today announced that it has been awarded a new contract with a major petrochemical company. The contract is for the supply of specialty chemicals used in the production of a variety of petrochemical products.
Transchem Limited Reports Strong Financial Results for 2022
Transchem Limited, a leading provider of specialty chemicals and services to the petrochemical industry, today reported strong financial results for the year ended December 31, 2022. The company's revenue increased by 10% to $1.2 billion, and its net income increased by 15% to $200 million.
Transchem Limited to Acquire Specialty Chemicals Company
Transchem Limited, a leading provider of specialty chemicals and services to the petrochemical industry, today announced that it has agreed to acquire a specialty chemicals company. The acquisition is expected to close in the second quarter of 2023.
Transchem Limited Announces Q4 and Full Year 2022 Financial Results
Transchem Limited (TCL) today announced its financial results for the fourth quarter and full year ended December 31, 2022.
Transchem Limited Provides Business Update and Outlook for 2023
Transchem Limited (TCL) today provided a business update and outlook for 2023.
Transchem Limited Announces Pricing of Public Offering of Common Shares
Transchem Limited (TCL) today announced the pricing of its public offering of 10,000,000 common shares at a price of $10.00 per share.